📌Biocon and Mylan have launched an insulin biosimilar ‘Semglee’ in Australia for the treatment of diabetes. Its Q2FY20 results are expected in a few days. Accumulate.
📌DHFL claims to have separated from the HDIL group in 2009 vide a family-separation agreement. This message may put at rest adverse thoughts. Buy selectively.
📌JSW Energy is likely to acquire GMR Energy. A positive for the company. Buy for the long term.
📌NTPC is eyeing some acquisitions in the PSU sector and its profitability is expected to rise by more than 15%. Buy for about 50% returns within a year.
📌Aurobindo Pharma is likely to resolve its USFDA issues soon. A nice bottom-fishing opportunity.
📌Indiabulls Housing Finance, which has a retired Supreme Court Judge, Ex-Dy RBI Governor and Ex-Director General of Police on its Board, has an institutional holding of ~65%. The rejection of its merger proposal with Lakshmi Vilas Bank should not dent its share price. Further, the proposed buy back indicates that the company has cash reserves and its CMP is below its intrinsic value. Accumulate.
📌Glenmark Pharmaceuticals is available at its 52-week low. The warning letter from USFDA may not affect its share price. Accumulate.
Indiabulls Real Estate is planning a buyback, which indicates that it not only has cash reserves 📌but also feels that its CMP is much below its intrinsic value. An attractive buy.
📌FMGC major, Britannia Industries, is working towards adding more products to its basket. The beaten down market conditions provide a good opportunity to accumulate this share.
📌PNB Housing Finance MD, SS Mallikarjuna Rao, sounds optimistic about the company’s future as NPA issues seem to have bottomed out. A positive for the company. Accumulate.
📌State Bank of India has reduced its lending rates by 10 bps across all tenors. With a reduction in both lending and deposit rates, its business prospects look stable. Accumulate.
📌The slide in IG Petrochemicals has phased out and the stock seems to have stabilised at its 52-week low. With an FY19 EPS of Rs.38, it paid a dividend of Rs.4/share. Accumulate.
📌Lupin has received GMP (good manufacturing practices) certificate from Japan’s drug regulator for its Mandideep API facility. The recent dip in its share price makes it an attractive buy.
📌Bharat Heavy Electricals has won a Rs.1600 crore turbine generator package order for 2×660 📌MW thermal power project in Uttar Pradesh. The sentiment in this counter could change shortly. Accumulate.
📌Goa Carbon reported a net loss of Rs.13.83 crore for Q2FY19 v/s a net loss of Rs.1.07 crore in Q2FY18 on account of lower sales. Stay away from this counter.
📌Munjal Group’s small-cap auto ancillary, Shivam Autotech, recorded lower sales amidst the slowdown in the auto industry. However, it is one of the largest manufacturers of transmission gears and shafts in India and can be bought at the current beaten down levels.
📌Titan Company reported weak H1FY20 results but the management claims that H2 is always better than the first half. Continue to hold.
📌Marico was one of the few companies which was not affected by the recent meltdown in the market. A good investment best in times of crises. Accumulate.
📌Shares of J.Kumar Infraprojects are being picked up by discerning investors as this construction major is expected to notch an EPS of Rs.26 for FY20. Accumulate.
📌Pitti Engineering is likely to notch an EPS of Rs.10.5 for FY20 when the full effect of its expansion is visible. Buy for 50% returns in the medium term.
📌RACL Geartech, the fastest growing auto component company, is set to notch an EPS of Rs.12 for FY20. The stock is poised to touch Rs.100.
📌Going by its FY19 EPS of Rs.34, Shreyans Industries is likely to notch an EPS of Rs.38 for FY20. The stock is likely to appreciate by over 50% in the medium term.
📌Polyplex Corporation posted 34% higher PAT for Q1FY20 and is likely to notch an EPS of Rs.140 for FY20. The stock is expected to cross Rs.700 on a conservative P/E of 5x